Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meiling Zheng

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Molecular Medicine (Cambridge, Mass.)|April 4, 2023
m<sup>6</sup>A methyltransferase METTL3 programs CD4<sup>+</sup> T-cell activation and effector T-cell differentiation in systemic lupus erythematosusShuang Lu, Xingyu Wei, Huan Zhu, et al.
Experimental & Molecular Medicine|November 19, 2025
RNA N<sup>6</sup>-methyladenosine reader protein YTHDF1 promotes plasma cell differentiation via IRF4 regulation in systemic lupus erythematosusShuang Lu, Xingyu Wei, Huan Zhu, et al.
Cell Reports. Medicine|April 2, 2024
Intratumor microbiome-derived butyrate promotes lung cancer metastasisYi Ma, Haiming Chen, Haoran Li, et al.
Molecular Diversity|February 26, 2025
Integrating network pharmacology, molecular docking, and bioinformatics to explore the mechanism of sparganii rhizoma in the treatment of laryngeal cancerMeiling Zheng, Rui Zhang, Xinxing Yang, et al.
Blood|January 21, 2017
Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphomaSophia Gayle, Sean Landrette, Neil Beeharry, et al.
Bioorganic Chemistry|August 7, 2025
TQFL13, a novel synthetic derivative of thymoquinone (TQ), is more capable of inhibiting breast cancer progression than TQChunli Wei, Jingliang Cheng, Hui Zou, et al.
Journal of Cancer|September 9, 2024
Evaluation of ENG/CD105 expression, methylation, immuno-response, and cordycepin (CD) regulation as a novel biomarker of breast invasive carcinoma (BRCA)Dabing Li, Meiling Zheng, Wenqian Zhang, et al.
Scientific Reports|December 2, 2025
DHX36 plays an oncogenic role in breast cancer progression and invasivenessChunli Wei, Dongmei Xu, Jingliang Cheng, et al.
Journal of Translational Medicine|January 28, 2025
Single-cell analyses of intestinal epithelium reveal the dysregulation of gut immune microenvironment in systemic lupus erythematosusQiaolin Wang, Yutong Wu, Lianlian Ouyang, et al.
Discover Oncology|April 6, 2026
Sex determining region Y box protein 2 (SOX2) expression, alteration, regulation and its diagnostics, prognostics and therapeutics in lung cancerXia Jiang, Meiling Zheng, Lianmei Zhang, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Molecular Medicine (Cambridge, Mass.)|April 4, 2023
m<sup>6</sup>A methyltransferase METTL3 programs CD4<sup>+</sup> T-cell activation and effector T-cell differentiation in systemic lupus erythematosusShuang Lu, Xingyu Wei, Huan Zhu, et al.
Experimental & Molecular Medicine|November 19, 2025
RNA N<sup>6</sup>-methyladenosine reader protein YTHDF1 promotes plasma cell differentiation via IRF4 regulation in systemic lupus erythematosusShuang Lu, Xingyu Wei, Huan Zhu, et al.
Cell Reports. Medicine|April 2, 2024
Intratumor microbiome-derived butyrate promotes lung cancer metastasisYi Ma, Haiming Chen, Haoran Li, et al.
Molecular Diversity|February 26, 2025
Integrating network pharmacology, molecular docking, and bioinformatics to explore the mechanism of sparganii rhizoma in the treatment of laryngeal cancerMeiling Zheng, Rui Zhang, Xinxing Yang, et al.
Blood|January 21, 2017
Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphomaSophia Gayle, Sean Landrette, Neil Beeharry, et al.
Bioorganic Chemistry|August 7, 2025
TQFL13, a novel synthetic derivative of thymoquinone (TQ), is more capable of inhibiting breast cancer progression than TQChunli Wei, Jingliang Cheng, Hui Zou, et al.
Journal of Cancer|September 9, 2024
Evaluation of ENG/CD105 expression, methylation, immuno-response, and cordycepin (CD) regulation as a novel biomarker of breast invasive carcinoma (BRCA)Dabing Li, Meiling Zheng, Wenqian Zhang, et al.
Scientific Reports|December 2, 2025
DHX36 plays an oncogenic role in breast cancer progression and invasivenessChunli Wei, Dongmei Xu, Jingliang Cheng, et al.
Journal of Translational Medicine|January 28, 2025
Single-cell analyses of intestinal epithelium reveal the dysregulation of gut immune microenvironment in systemic lupus erythematosusQiaolin Wang, Yutong Wu, Lianlian Ouyang, et al.
Discover Oncology|April 6, 2026
Sex determining region Y box protein 2 (SOX2) expression, alteration, regulation and its diagnostics, prognostics and therapeutics in lung cancerXia Jiang, Meiling Zheng, Lianmei Zhang, et al.
Pageof 11